HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Catherine Thieblemont Selected Research
Catherine Thieblemont Research Topics
Disease
48
Lymphoma (Lymphomas)
12/2022 - 12/2002
41
Neoplasms (Cancer)
12/2022 - 02/2003
38
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022 - 09/2009
25
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 10/2005
23
B-Cell Lymphoma (Lymphoma, B Cell)
11/2022 - 03/2005
11
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2004
9
Infections
01/2022 - 02/2012
8
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 08/2010
8
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2022 - 02/2003
7
Disease Progression
01/2022 - 08/2012
6
Hodgkin Disease (Hodgkin's Disease)
11/2016 - 07/2004
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2022 - 04/2004
5
Neutropenia
01/2022 - 05/2013
4
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 09/2013
3
Multiple Myeloma
06/2022 - 07/2004
3
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022 - 03/2005
3
Febrile Neutropenia
01/2022 - 04/2011
3
Cytokine Release Syndrome
11/2021 - 11/2020
3
Cytopenia
08/2014 - 06/2002
2
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 03/2005
2
Fever (Fevers)
01/2022 - 08/2012
2
COVID-19
12/2021 - 01/2020
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2021 - 11/2015
2
Extranodal NK-T-Cell Lymphoma
01/2021 - 02/2011
2
Residual Neoplasm
11/2020 - 03/2016
2
Fatigue
01/2020 - 01/2019
2
Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 01/2013
2
Tumor Lysis Syndrome
10/2014 - 08/2013
2
Acute Kidney Injury (Acute Renal Failure)
10/2014 - 08/2013
1
Agammaglobulinemia (Hypogammaglobulinemia)
01/2022
1
Lymphopenia (Lymphocytopenia)
01/2022
Drug/Important Bio-Agent (IBA)
41
Rituximab (Mabthera)
FDA Link
03/2022 - 01/2004
11
Chimeric Antigen Receptors
IBA
11/2022 - 01/2020
11
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2019 - 03/2003
10
obinutuzumab
IBA
01/2022 - 05/2012
10
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2019 - 03/2003
10
Vincristine (Oncovin)
FDA Link
Generic
01/2019 - 03/2003
10
Prednisone (Sone)
FDA Link
Generic
01/2019 - 03/2003
9
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2022 - 08/2010
8
ibrutinib
IBA
03/2022 - 08/2014
8
Biological Products
IBA
01/2022 - 02/2012
8
Lenalidomide (CC 5013)
FDA Link
01/2022 - 01/2012
6
axicabtagene ciloleucel
IBA
11/2022 - 11/2020
6
selinexor
IBA
02/2022 - 07/2020
6
Monoclonal Antibodies
IBA
10/2016 - 12/2002
5
Agammaglobulinaemia Tyrosine Kinase
IBA
03/2022 - 08/2014
5
Dexamethasone (Maxidex)
FDA Link
Generic
11/2020 - 08/2010
5
Proteins (Proteins, Gene)
FDA Link
10/2019 - 04/2011
4
Biomarkers (Surrogate Marker)
IBA
12/2022 - 10/2020
4
tisagenlecleucel
IBA
01/2022 - 11/2020
4
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2022 - 05/2013
4
Anti-Bacterial Agents (Antibiotics)
IBA
10/2021 - 02/2003
4
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 11/2011
4
Chlorambucil (Leukeran)
FDA Link
06/2017 - 03/2003
3
idelalisib
IBA
02/2022 - 01/2018
3
Transcription Factors (Transcription Factor)
IBA
02/2022 - 01/2020
3
Bendamustine Hydrochloride
FDA Link
01/2022 - 02/2017
3
Adrenal Cortex Hormones (Corticosteroids)
IBA
11/2021 - 12/2015
3
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2021 - 08/2010
3
Carboplatin (JM8)
FDA Link
Generic
01/2021 - 11/2011
3
Immunoglobulins (Immunoglobulin)
IBA
12/2018 - 03/2005
3
Pharmaceutical Preparations
IBA
01/2018 - 08/2014
3
Etoposide (VP 16)
FDA Link
Generic
10/2016 - 04/2011
3
Ifosfamide
FDA Link
Generic
10/2016 - 04/2011
3
DNA (Deoxyribonucleic Acid)
IBA
07/2015 - 03/2009
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
12/2022 - 01/2021
2
NF-kappa B (NF-kB)
IBA
02/2022 - 01/2020
2
Histone Deacetylase Inhibitors
IBA
01/2022 - 04/2015
2
Immunoglobulin M (IgM)
IBA
01/2022 - 03/2005
2
romidepsin (FK228)
FDA Link
01/2022 - 04/2015
2
tocilizumab (atlizumab)
FDA Link
11/2021 - 01/2021
2
Methotrexate (Mexate)
FDA Link
Generic
04/2021 - 02/2011
2
Antiviral Agents (Antivirals)
IBA
01/2020 - 03/2015
2
Asparaginase (Elspar)
FDA Link
01/2019 - 02/2011
2
OTX015
IBA
04/2016 - 03/2016
2
Histones (Histone)
IBA
01/2016 - 04/2011
2
Bleomycin (Blenoxane)
FDA Link
Generic
12/2014 - 04/2011
2
rasburicase (Elitek)
FDA Link
10/2014 - 08/2013
2
tipifarnib (R115777)
IBA
03/2010 - 04/2008
2
Farnesyltranstransferase (Farnesyltransferase)
IBA
03/2010 - 04/2008
2
Antigens
IBA
05/2006 - 04/2005
1
Salts
IBA
03/2022
1
Platinum
IBA
03/2022
1
Globulins
IBA
01/2022
1
blinatumomab
IBA
01/2022
1
atezolizumab
IBA
01/2022
Therapy/Procedure
50
Therapeutics
11/2022 - 12/2002
24
Stem Cell Transplantation
06/2022 - 10/2005
18
Drug Therapy (Chemotherapy)
01/2022 - 12/2002
6
Transplantation
01/2022 - 01/2017
5
Splenectomy
12/2018 - 06/2002
4
Radiotherapy
10/2021 - 11/2011
3
Immunotherapy
06/2022 - 12/2018
3
Hematopoietic Stem Cell Transplantation
01/2021 - 08/2012
2
Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 08/2010
2
Induction Chemotherapy
11/2020 - 01/2020
2
Salvage Therapy
11/2011 - 08/2010
1
Blood Component Removal (Apheresis)
01/2022
1
Injections
01/2022
1
Kidney Transplantation
01/2022